Physician profile
Eugene Choi
NPI 1609960681
$7,248.97
in general payments reported to CMS, 2019-2025
7 companies · $34.40 in 2025
The $34.40 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,092 · 2020: $54.76 · 2021: $27.53 · 2022: $20.27 · 2023: $442 · 2024: $578 · 2025: $34.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $998 · Food and Beverage: $56.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $997.61 |
| Food and Beverage | $56.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,113.41 | 2019-2020 | |
| Stryker Corporation | $997.61 | 2023-2024 | 1788, 1688 |
| Tela Bio, INC. | $49.48 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $34.40 | 2025 | Renasys Touch |
| Misonix INC | $22.47 | 2020 | |
| Glaxosmithkline, LLC. | $20.27 | 2022 | |
| Wound Management Technologies, INC | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.